Gabriel, Lourdes M.
HRN: 21-74-59 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
08/03/2022
08/10/2022
IV
1.5g
Q6
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes